1LEVINE S, HERNANDEZ D, YAMANAKA G, et al. Efficacies of entecavir against lamivudine-resistant hepatitis B virus replication and recombinant polymerases in vitro [J] . Antimicrob Agents Chemother,2002, 46(8) :2525 - 2532.
2GISH R G,DE MAN R A,PEDERSEN C,et al. Sustained response off-treatment to entecavir and lamivudine after 48 weeks of treatment in nucleoside-naYve, HBeAg+ patients : 24-week follow-up results of phase 3 study ETV-022 [J]. J Hepatol,2005, 42(Suppl 2) : 177.
3CHANG T T, GISH R G, DE MAN R, et al. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B [J]. N Engl J Med, 2006, 354(10) :1001 - 1010.
4I.AI C L, ROSMAWATI M, LAO J, et al.Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection [J].Gastroenterology, 2002, 123(6): 1831 -1838.
5COLONNO B J,BOSE R E,LEVINE S M,et al. Emergence of cntecavir resistant hepatitis B virus after one year of therapyin phase Ⅱ & Ⅲ studies is onlyobserved in lamivudine refractory patients[J] . Hepatology, 2004, 40(4 Suppl 1):661A.
6LAI C L, LEUNG N W Y, TEO E K, et al.Results of a one-year international phase ⅡB comparative trial of telbivudine,lamivudlne, and the combination in patients with chronic hepatitis B [J] . Hepatology,2003, 38 (4 Suppl 1 ) :262A.
7HANS H, LEUNG N W, TEO E K, et al.Results of a one-year international phase ⅡB trial of LDT, and LDT plus lamivudine, in patients with chronic hepatitis B [J] . J Hepatol,2004,40 (Suppl 1 ) : 16.
8LAI C L, GANE E, LIAW y F, et al.Telbivudine (LdT) vs lamivudine for chronichepatitis B: first-year results from the International Phase Ⅲ GLOBE Trial [J].Hepatology, 2005, 42 (Suppl 11 ) : 748A.
9VAN BOMMEL F, SCHERNICK A, HOPF U, et al. Tenofovir disoproxil fumarate exhibits strong antiviral effect in a patient with lamivudine-resistant severe hepatitis Breactivation [J] . Gastroenterology, 2003,124(2) :586 - 587.
10NUNEZ M, PEREZ-OLMEDA M, DIAZ B,et al. Activity of tenofovlr on hepatitis Bvirus repllcation in HIV-co-infected patients failing or partially responding to lamivudine[J]. AIDS,2002, 16(17) :2352 -2354.
